Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: A report on toxicity and efficacy from a prospective pilot phase II study-Reference-Cited by-同舟云学术

Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: A report on toxicity and efficacy from a prospective pilot phase II study

Published:2012-05-22 Issue:2 Volume:60 Page:242-247
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Dharmarajan Kavita V.,Wexler Leonard H.,Wolden Suzanne L.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24205/fullpdf

Reference25 articles.

1. The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major lessons From the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols;Raney;Sarcoma,2001

2. Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: An intergroup rhabdomyosarcoma study;Pappo;J Clin Oncol,2001

3. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: A Children's Oncology Group study;Walterhouse;J Clin Oncol,2004

4. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: A Pediatric Oncology Group phase II study;Saylors;J Clin Oncol,2001

5. Topotecan in pediatric patients with recurrent and progressive solid tumors: A Pediatric Oncology Group phase II study;Nitschke;J Pediatr Hematol Oncol,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orbital Rhabdomyosarcoma: Comprehensive Review of Epidemiology, Clinical Staging, and Treatment Outcomes;World Neurosurgery;2024-07

2. The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma;Cancers;2024-02-29

3. Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates;Oncology Research and Treatment;2023-11-28

4. Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma;Biochemical Pharmacology;2023-02

5. Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression;International Journal of Molecular Sciences;2023-01-03